Unlocking The Potential of SUPT7L for Neurodegenerative Disease Research

Target Name: SUPT7L

NCBI ID: G9913

SUPT7L

Unlocking The Potential of SUPT7L for Neurodegenerative Disease Research

SUPT7L (STAF65(gamma)) is a protein that is expressed in the brain and is known for its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. The protein is encoded by the STAF65 gene and is expressed in the brain, heart, and kidneys.

SUPT7L is a 7-kDa transmembrane protein that is expressed in the brain and is involved in the regulation of synaptic plasticity. It is a scaffold protein that is involved in the formation and maintenance of the synaptic scaffold, which is a structure that surrounds the synapses and is involved in the transfer of vesicles and neurotransmitters.

SUPT7L is involved in the regulation of neurotransmitter release and in the modulation of synaptic plasticity. It has been shown to play a role in the regulation of dopamine release and has been shown to interact with the neurotransmitter receptor D2.

In addition to its role in synaptic plasticity, SUPT7L is also involved in the regulation of cell survival and in the development of neurodegenerative diseases. It has been shown to play a role in the development of Alzheimer's disease and other forms of neurodegenerative disease.

Despite the importance of SUPT7L in the regulation of synaptic plasticity, much is still not known about its function and the mechanisms that are involved in its regulation. Further research is needed to fully understand the role of SUPT7L in neurodegenerative disease and to identify potential drug targets or biomarkers for this protein.

In conclusion, SUPT7L is a protein that is involved in the regulation of synaptic plasticity and has been shown to play a role in the development of neurodegenerative disease. Further research is needed to fully understand its function and to identify potential drug targets or biomarkers for this protein.

Protein Name: SPT7 Like, STAGA Complex Subunit Gamma

The "SUPT7L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUPT7L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets